Literature DB >> 19386588

MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN).

Rocio T Martinez-Nunez1, Fethi Louafi, Peter S Friedmann, Tilman Sanchez-Elsner.   

Abstract

MicroRNA-155 (miR-155) has been involved in the response to inflammation in macrophages and lymphocytes. Here we show how miR-155 participates in the maturation of human dendritic cells (DC) and modulates pathogen binding by down-regulating DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN), after directly targeting the transcription factor PU.1. During the maturation of DCs, miR-155 increases up to 130-fold, whereas PU.1 protein levels decrease accordingly. We establish that human PU.1 is a direct target for miR-155 and localize the target sequence for miR-155 in the 3'-untranslated region of PU.1. Also, overexpression of miR-155 in the THP1 monocytic cell line decreases PU.1 protein levels and DC-SIGN at both the mRNA and protein levels. We prove a link between the down-regulation of PU.1 and reduced transcriptional activity of the DC-SIGN promoter, which is likely to be the basis for its reduced mRNA expression, after miR-155 overexpression. Finally, we show that, by reducing DC-SIGN in the cellular membrane, miR-155 is involved in regulating pathogen binding as dendritic cells exhibited the lower binding capacity for fungi and HIV protein gp-120 when the levels of miR-155 were higher. Thus, our results suggest a mechanism by which miR-155 regulates proteins involved in the cellular immune response against pathogens that could have clinical implications in the way pathogens enter the human organism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386588      PMCID: PMC2713543          DOI: 10.1074/jbc.M109.011601

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

Authors:  T B Geijtenbeek; R Torensma; S J van Vliet; G C van Duijnhoven; G J Adema; Y van Kooyk; C G Figdor
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

2.  DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

Authors:  T B Geijtenbeek; D J Krooshoop; D A Bleijs; S J van Vliet; G C van Duijnhoven; V Grabovsky; R Alon; C G Figdor; Y van Kooyk
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

Review 3.  Dendritic-cell control of pathogen-driven T-cell polarization.

Authors:  Martien L Kapsenberg
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

4.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.

Authors:  Richard Dahl; Jonathan C Walsh; David Lancki; Peter Laslo; Sangeeta R Iyer; Harinder Singh; M Celeste Simon
Journal:  Nat Immunol       Date:  2003-09-07       Impact factor: 25.606

6.  The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells.

Authors:  Alessandra Cambi; Karlijn Gijzen; l Jolanda M de Vries; Ruurd Torensma; Ben Joosten; Gosse J Adema; Mihai G Netea; Bart-Jan Kullberg; Luigina Romani; Carl G Figdor
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

7.  Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes.

Authors:  María Colmenares; Amaya Puig-Kröger; Oscar Muñiz Pello; Angel L Corbí; Luis Rivas
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

8.  Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.

Authors:  Gregory T Spear; M Reza Zariffard; Ji Xin; Mohammed Saifuddin
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

10.  Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.

Authors:  Ryan M O'Connell; Dinesh S Rao; Aadel A Chaudhuri; Mark P Boldin; Konstantin D Taganov; John Nicoll; Ronald L Paquette; David Baltimore
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307

View more
  95 in total

Review 1.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

2.  miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate.

Authors:  Mati Mann; Omer Barad; Reuven Agami; Benjamin Geiger; Eran Hornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-18       Impact factor: 11.205

3.  Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer.

Authors:  Juan R Cubillos-Ruiz; Jason R Baird; Amelia J Tesone; Melanie R Rutkowski; Uciane K Scarlett; Ana L Camposeco-Jacobs; Jorge Anadon-Arnillas; Noah M Harwood; Murray Korc; Steven N Fiering; Lorenzo F Sempere; Jose R Conejo-Garcia
Journal:  Cancer Res       Date:  2012-02-03       Impact factor: 12.701

Review 4.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

5.  MicroRNA expressions associated with eosinophilic meningitis caused by Angiostrongylus cantonensis infection in a mouse model.

Authors:  L Yu; Q Liao; X Zeng; Z Lv; H Zheng; Y Zhao; X Sun; Z Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-30       Impact factor: 3.267

6.  MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}.

Authors:  Fethi Louafi; Rocio T Martinez-Nunez; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

7.  The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).

Authors:  Rocio T Martinez-Nunez; Fethi Louafi; Tilman Sanchez-Elsner
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

Review 8.  Modulation of immune responses following solid organ transplantation by microRNA.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Sabarinathan Ramachandran; Jeffrey Crippin; William Chapman; T Mohanakumar
Journal:  Exp Mol Pathol       Date:  2012-10-01       Impact factor: 3.362

9.  NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.

Authors:  D Gerloff; R Grundler; A A Wurm; D Bräuer-Hartmann; C Katzerke; J-U Hartmann; V Madan; C Müller-Tidow; J Duyster; D G Tenen; D Niederwieser; G Behre
Journal:  Leukemia       Date:  2014-08-05       Impact factor: 11.528

10.  Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway.

Authors:  Qiu-Liang Liu; Jiao Zhang; Xin Liu; Jing-Yao Gao
Journal:  Cell Prolif       Date:  2015-08-20       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.